HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO-B

416.600

+4.0000.97%

Volume:95.50K

Turnover:39.63M

Market Cap:97.15B

PE:-346.14

High:419.800

Open:410.400

Low:407.600

Close:412.600

52wk High:581.000

52wk Low:183.100

Shares:233.19M

HK Float Shares:162.77M

Volume Ratio:0.23

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.204

ROE:-17.56%

ROA:-9.92%

PB:17.11

PE(LYR):-346.14

PS:57.18

Loading ...

Overview Company News Filings

BUZZ-Crescent Biopharma rises as global trial for new cancer drug starts

SKB BIO-B Falls 3.33% Against Market Trend, Weighed by Sector Weakness and Divergent Institutional Views

China International Capital Maintains Outperform Rating on SKB BIO-B (06990) with HK$550 Target Price

Goldman Sachs: Mainland Healthcare Sector Returns to Hinge on Data and Earnings Visibility This Year, CDMO Firms Favored

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Trop2 Adc Sacituzumab Tirumotecan Approved For Marketing For Fourth Indication By China's NMPA

Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (Sac-TMT) Approved by Nmpa in Hr+/Her2- Breast Cancer

THOMSON REUTERS

Sichuan Kelun-Biotech (6990) Announces Fourth NMPA Approval of TROP2 ADC Sacituzumab Tirumotecan for Advanced HR+/HER2- Breast Cancer

Bulletin Express

SKB BIO-B's Core TROP2 ADC Therapy Sac-TMT Gains Fourth Indication Approval in China for HR+/HER2- Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical - Trop2 ADC Sacituzumab Tirumotecan Approved for Marketing for Fourth Indication by Nmpa

THOMSON REUTERS

Sichuan Kelun-Biotech Receives NMPA Approval for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer

Kelun-Biotech (06990) Releases January 2026 Monthly Return

Bulletin Express

Sichuan Kelun-Biotech Renews R&D Procurement Deal With China Resources Kelun; Shares Slip 5%

MT Newswires Live

Does Breakthrough Status For Sacituzumab Tirumotecan-Keytruda Combo Reshape Kelun-Biotech’s Oncology Strategy (SEHK:6990)?

Simply Wall St.

Kelun-Biotech Releases Latest Corporate Presentation Document

Why Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Is Up 18.9% After Breakthrough ADC Milestones And Global Tie-Up

Simply Wall St.

Kelun-Bota Biotech-B (06990) Terminates Subscription of 980 Million Yuan Bank of China Structured Deposit

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Subscription For BOC Structured Deposit II Terminated

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Subscription for BOC Structured Deposit Ii Terminated

THOMSON REUTERS

Kelun-Biotech to Present Business Progress and Innovation Strategies at J.P. Morgan Healthcare Conference

Kelun-Biotech to Attend the 44TH J.p. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/06990/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO-B","latestPrice":416.6,"timestamp":1771574918009,"preClose":412.6,"halted":0,"volume":95500,"delay":0,"changeRate":0.009694619486185167,"floatShares":162769979,"shares":233185969,"eps":-1.203559,"marketStatus":"Market Closed","change":4,"latestTime":"02-20 16:08:38","open":410.4,"high":419.8,"low":407.6,"amount":39632120,"amplitude":0.029569,"askPrice":416.6,"askSize":6300,"bidPrice":415.6,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-3.508831,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771810200000},"marketStatusCode":7,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":412.6,"openAndCloseTimeList":[[1771551000000,1771560000000],[1771563600000,1771574400000]],"volumeRatio":0.22509739500416204,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-9.92%","roe":"-17.56%","lyrEps":-1.203559,"volumeRatio":0.22509739500416204,"shares":233185969,"dividePrice":0,"high":419.8,"amplitude":0.029569,"preClose":412.6,"low":407.6,"week52Low":183.1,"pbRate":"17.11","psRate":"57.18","week52High":581,"institutionHeld":0,"latestPrice":416.6,"committee":-0.909091,"eps":-1.203559,"divideRate":0,"volume":95500,"delay":0,"ttmEps":-3.508831,"open":410.4,"prevYearClose":392.2,"prevWeekClose":418.6,"prevMonthClose":415.4,"prevQuarterClose":392.2,"fiveDayClose":437.2,"twentyDayClose":442.4,"sixtyDayClose":439.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post Market","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5263,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1764777600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-02-20","current":-118.729001,"percent":0.551938,"low":-351.800852,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"high":-21.029201,"avg":-126.654771,"sd":78.01089,"marketCap":97145274685},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685}],"updateTime":1771765597911},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612440859","title":"BUZZ-Crescent Biopharma rises as global trial for new cancer drug starts","url":"https://stock-news.laohu8.com/highlight/detail?id=2612440859","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612440859?lang=en_us&edition=fundamental","pubTime":"2026-02-19 01:00","pubTimestamp":1771434027,"startTime":"0","endTime":"0","summary":"BUZZ-Crescent Biopharma rises as global trial for new cancer drug starts** Shares of drugmaker Crescent Biopharma CBIO.O rise 4% to $9.68  ** Co says it has begun a global earlystage trial of CR001 for advanced solid tumors** CR001 is an experimental cancer drug designed to help the immune system attack tumors and block blood supply, CBIO says** Co says study will test safety and how the drug moves and acts in the body before checking for early signs of tumor shrinkage** Trial to enroll up to 290 patients across the U.S., Europe and Asia Pacific; initial data expected in early 2027, CBIO says** Co says it has granted China-based cancerdrug developer Sichuan Kelun-Biotech exclusive rights to develop and sell the drug in Greater China** Shares down ~52% in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL4N3ZE19W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU1979443071.USD","BK4139","BK0060","BK1161","LU1064131003.USD","LU0196878994.USD","LU1064130708.USD","CBIO","LU2148510915.USD","LU1934453819.USD","002422","BK0239"],"gpt_icon":0},{"id":"1185804801","title":"SKB BIO-B Falls 3.33% Against Market Trend, Weighed by Sector Weakness and Divergent Institutional Views","url":"https://stock-news.laohu8.com/highlight/detail?id=1185804801","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185804801?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:22","pubTimestamp":1770898930,"startTime":"0","endTime":"0","summary":"On February 12, 2026, SKB BIO-B (06990.HK) declined by 3.33% against the broader market trend, closing at HKD 423.40 with a turnover of HKD 208 million. The drop was primarily influenced by the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1182049963","title":"China International Capital Maintains Outperform Rating on SKB BIO-B (06990) with HK$550 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1182049963","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182049963?lang=en_us&edition=fundamental","pubTime":"2026-02-11 09:58","pubTimestamp":1770775114,"startTime":"0","endTime":"0","summary":"China International Capital (CICC) has essentially kept its forecasts for SKB BIO-B's (06990) net profit attributable to shareholders for 2025 and 2026 unchanged. Benefiting from the overseas...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"1133857400","title":"Goldman Sachs: Mainland Healthcare Sector Returns to Hinge on Data and Earnings Visibility This Year, CDMO Firms Favored","url":"https://stock-news.laohu8.com/highlight/detail?id=1133857400","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133857400?lang=en_us&edition=fundamental","pubTime":"2026-02-09 14:17","pubTimestamp":1770617841,"startTime":"0","endTime":"0","summary":"According to a research report from Goldman Sachs, the strong trends observed in the mainland healthcare sector last year are expected to continue into this year. However, investors are increasingly...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","02359","BK1191","HK0000320264.USD","BK1141","03692","159891","LU0320764599.SGD","HK0000306701.USD","LU0708995583.HKD","02696","BK1161","LU2045819591.USD","02268","HK0000165453.HKD","06990","LU2125910500.SGD","LU0052750758.USD","BK1576","LU1046422090.SGD","LU2242644610.SGD","LU2488822045.USD","BK1589","HK0000306685.HKD","CDMO","BK4139","SG9999014674.SGD","BK1583","HK0000320223.HKD"],"gpt_icon":0},{"id":"2609564818","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Trop2 Adc Sacituzumab Tirumotecan Approved For Marketing For Fourth Indication By China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2609564818","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609564818?lang=en_us&edition=fundamental","pubTime":"2026-02-06 18:33","pubTimestamp":1770374008,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Trop2 Adc Sacituzumab Tirumotecan Approved For Marketing For Fourth Indication By China's NMPAFeb 6  - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:TROP2 ADC SACITUZUMAB TIRUMOTECAN APPROVED FOR MARKETING FOR FOURTH INDICATION BY NMPAFurther company coverage: 6990.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z122A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2609565148","title":"Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (Sac-TMT) Approved by Nmpa in Hr+/Her2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2609565148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609565148?lang=en_us&edition=fundamental","pubTime":"2026-02-06 17:00","pubTimestamp":1770368400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA8VLKFG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"1150343342","title":"Sichuan Kelun-Biotech (6990) Announces Fourth NMPA Approval of TROP2 ADC Sacituzumab Tirumotecan for Advanced HR+/HER2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1150343342","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150343342?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:44","pubTimestamp":1770367456,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Stock Code: 6990) announced that the National Medical Products Administration (NMPA) of China has approved a new indication for sacituzumab...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"1148301809","title":"SKB BIO-B's Core TROP2 ADC Therapy Sac-TMT Gains Fourth Indication Approval in China for HR+/HER2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1148301809","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148301809?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:41","pubTimestamp":1770367273,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) announced that its TROP2-targeting antibody-drug conjugate (ADC), sacituzumab govitecan (sac-TMT, also known as SKB264/MK-2870), has received approval from China's National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","HR","06990","BK1161","BK4203","BK4225"],"gpt_icon":0},{"id":"2609563682","title":"Sichuan Kelun-Biotech Biopharmaceutical - Trop2 ADC Sacituzumab Tirumotecan Approved for Marketing for Fourth Indication by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609563682?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:34","pubTimestamp":1770366894,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z122A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2609635275","title":"Sichuan Kelun-Biotech Receives NMPA Approval for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2609635275","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609635275?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:33","pubTimestamp":1770366831,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced that its TROP2-directed antibody-drug conjugate , sacituzumab tirumotecan , has been approved by the National Medical Products Administration  of China for a new indication. The approval covers the treatment of adult patients with unresectable or metastatic hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative  breast cancer who have received at least one prior systemic therapy. This marks the fourth approved indication for sac-TMT by the NMPA.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL47X09v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","002422","BK1161","LU1064131003.USD","LU1064130708.USD","LU2148510915.USD","LU0196878994.USD","LU1934453819.USD","BK0239","BK0060","LU1979443071.USD"],"gpt_icon":0},{"id":"1117718675","title":"Kelun-Biotech (06990) Releases January 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1117718675","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117718675?lang=en_us&edition=fundamental","pubTime":"2026-02-04 16:47","pubTimestamp":1770194858,"startTime":"0","endTime":"0","summary":"Kelun-Biotech (06990) disclosed its monthly return for the period ended 31 January 2026. The company’s total authorized share capital stood at RMB 233,185,969, reflecting no change during the month....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2604902191","title":"Sichuan Kelun-Biotech Renews R&D Procurement Deal With China Resources Kelun; Shares Slip 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604902191","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604902191?lang=en_us&edition=fundamental","pubTime":"2026-01-19 12:54","pubTimestamp":1768798473,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  entered into a new transaction framework to procure R&D-related goods from China Resources Kelun  Medicine, according to a Jan. 16 Hong Kong bourse filing.Shares of the biopharmaceutical firm were down over 5% in Monday's midday trade.The agreement covers the procurement of R&D-related drugs, consumables, and fixed assets for a term ending Dec. 31, 2028.It replaces a previous framework agreement that expired at the end of 2025.Kelun-Biotech set annual caps of nearly 10.7 million yuan for each of 2026, 2027, and 2028, the filing showed.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2604944685","title":"Does Breakthrough Status For Sacituzumab Tirumotecan-Keytruda Combo Reshape Kelun-Biotech’s Oncology Strategy (SEHK:6990)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2604944685","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604944685?lang=en_us&edition=fundamental","pubTime":"2026-01-17 12:34","pubTimestamp":1768624447,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical recently announced that its TROP2-directed ADC sacituzumab tirumotecan, combined with MSD’s KEYTRUDA, received Breakthrough Therapy Designation in China for first-line treatment of certain advanced non-small cell lung cancer patients, while its CEO highlighted pipeline progress and globalisation plans at the J.P. Morgan Healthcare Conference.\nThe clustering of multiple Breakthrough Therapy Designations around sacituzumab tirumotecan, alongside...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/does-breakthrough-status-for-sacituzumab-tirumotecan-keytrud","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/does-breakthrough-status-for-sacituzumab-tirumotecan-keytrud","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0320765646.SGD","IE00BLSP4452.SGD","LU0203347892.USD","LU0130517989.USD","LU1934455863.HKD","LU1035773651.USD","LU0098860793.USD","LU1941712264.USD","IE0002141913.USD","IE0009355771.USD","LU1066053197.SGD","LU0965509101.SGD","LU0211331839.USD","BK4588","LU1066051498.USD","LU1037948541.HKD","IE00BBT3K403.USD","LU1989772840.SGD","BK4516","IE00BFTCPJ56.SGD","LU2023250843.SGD","LU1974910355.USD","LU0648001328.SGD","SG9999014575.USD","BK4585","LU0238689110.USD","LU0203345920.USD","LU2125154778.USD","06990","LU0320765489.SGD","LU2324357040.USD","LU0861579265.USD","LU1057294990.SGD","LU0265550946.USD","BK4559","LU1201861249.SGD","LU2125154935.USD","LU0070302665.USD","LU1162221912.USD","LU2461242641.AUD","SG9999015341.SGD","LU2023250504.SGD","SGXZ57979304.SGD","LU1571399168.USD","LU0058720904.USD","LU2468319806.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","SG9999002232.USD","LU1929549753.HKD","LU0265550359.USD","LU1934455277.USD","LU1699723380.USD","LU1917777945.USD","LU1069347547.HKD","SG9999013999.USD","LU0980610538.SGD","LU1989772923.USD","LU0289739699.SGD","IE000M9KFDE8.USD","SG9999014559.SGD","IE00B2B36J28.USD","LU1291159041.SGD","LU1023059063.AUD","LU1066051225.USD","BK4534","LU0477156953.USD","BK4007","LU0965509010.AUD","LU1430594728.SGD","LU0130102774.USD","LU0965508806.USD","SG9999001440.SGD","LU2106854487.HKD","BK4550","LU1116320901.HKD","IE00BJT1NW94.SGD","SG9999014542.SGD","LU1061106388.HKD","LU0122379950.USD","LU2361044865.SGD","LU0965509283.SGD","SG9999015358.SGD","LU0985320562.USD","LU2361044949.HKD","LU1941712348.USD","SG9999014567.USD","BK4533","LU1037948897.HKD","LU2360032135.SGD","SG9999001176.SGD","BK1161","LU2112291526.USD","IE00BSNM7G36.USD","LU0106261372.USD","SG9999002224.SGD","LU1934455194.USD","LU0006306889.USD","LU0208291251.USD","SG9999001176.USD","LU0266013472.USD","LU2361045086.USD","LU2089984988.USD","LU1116320737.USD","IE00BLSP4239.USD","LU1989771016.USD","LU1093756325.SGD","LU1585245621.USD","LU0196878994.USD","LU1093756168.USD","LU0234572021.USD","LU1066051811.HKD","IE00BN8TJ469.HKD"],"gpt_icon":0},{"id":"2603980939","title":"Kelun-Biotech Releases Latest Corporate Presentation Document","url":"https://stock-news.laohu8.com/highlight/detail?id=2603980939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603980939?lang=en_us&edition=fundamental","pubTime":"2026-01-16 02:30","pubTimestamp":1768501819,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has published the presentation materials from the 44th J.P. Morgan Healthcare Conference. For more details, please refer to the \"Investor Relations-Investor Calendar\" page of the company's official website: Investor Relations-Investor Calendar.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via PR Newswire  on January 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL9MB0xr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","LU1064130708.USD","LU2148510915.USD","BK1161","BK0239","002422","LU1979443071.USD","06990","LU1934453819.USD","LU1064131003.USD","BK0060"],"gpt_icon":0},{"id":"2602300920","title":"Why Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) Is Up 18.9% After Breakthrough ADC Milestones And Global Tie-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2602300920","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602300920?lang=en_us&edition=fundamental","pubTime":"2026-01-10 01:19","pubTimestamp":1767979187,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical recently reported that its TROP2-directed ADC sacituzumab tirumotecan, combined with pembrolizumab, received Breakthrough Therapy Designation in China for first-line PD-L1-positive NSCLC, while its ITGB6-targeted ADC SKB105 secured IND approval for advanced solid tumors and a new global collaboration with Crescent Biopharma was announced.\nThese developments, alongside multiple ongoing registrational and Phase 3 trials and structured distribution and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/why-sichuan-kelun-biotech-biopharmaceutical-sehk6990-is-up-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/why-sichuan-kelun-biotech-biopharmaceutical-sehk6990-is-up-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","ADC","BK4080","BK4231","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"1116767445","title":"Kelun-Bota Biotech-B (06990) Terminates Subscription of 980 Million Yuan Bank of China Structured Deposit","url":"https://stock-news.laohu8.com/highlight/detail?id=1116767445","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116767445?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:53","pubTimestamp":1767797582,"startTime":"0","endTime":"0","summary":"Kelun-Bota Biotech-B (06990) announced the termination of its subscription to a Bank of China structured deposit II with a principal amount of RMB 980 million. The company ended this subscription on...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1515016050.SGD","BK0028","LU1497733631.SGD","601988","LU1497733557.USD","LU1282651048.USD","SG9999001093.SGD","LU2097828474.EUR","LU0307460666.USD","LU1224444064.USD","LU0293314216.USD","LU2097828714.EUR","06990","LU0348805143.USD","LU1051769294.HKD","03143","IE00BWDBJ730.SGD","LU1634259557.SGD","LU1497734951.SGD","03988","IE00BQJZWZ67.USD","LU1522347837.USD","LU2097828805.USD","BK1231","BK0278","LU0588546209.SGD","BK0015","LU1048588211.SGD","LU1634259391.SGD","IE00B19Z5X02.USD","LU0196878994.USD","BK0188","LU0651946864.USD","BK0012","BK1161","LU1282651121.HKD","LU0072462343.USD","SG9999006597.SGD","BK1521","BK1560","LU0651947912.USD","LU1051768304.USD","LU2097828557.USD","BK0183","LU2097828631.EUR"],"gpt_icon":0},{"id":"2601889804","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Subscription For BOC Structured Deposit II Terminated","url":"https://stock-news.laohu8.com/highlight/detail?id=2601889804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601889804?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:51","pubTimestamp":1767797468,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Says Subscription For BOC Structured Deposit II TerminatedJan 7 (Reuters) - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:SUBSCRIPTION FOR BOC ST","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y80DG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2601801797","title":"Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Subscription for BOC Structured Deposit Ii Terminated","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601801797?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:47","pubTimestamp":1767797242,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y80DG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2601281568","title":"Kelun-Biotech to Present Business Progress and Innovation Strategies at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2601281568","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601281568?lang=en_us&edition=fundamental","pubTime":"2026-01-07 10:45","pubTimestamp":1767753902,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is set to attend the 44th J.P. Morgan Healthcare Conference in San Francisco, California, from January 12 to 15, 2026. Dr. Michael Ge, President and CEO of Kelun-Biotech, will deliver a presentation on Thursday, January 15, 2026, at 9:30 AM Pacific Standard Time at the Westin St. Francis. The company will share its latest business progress and innovation strategies, and explore partnership opportunities at this major global healthcare industry event. A live webcast of the presentation will be available on Kelun-Biotech's official website, along with a replay for 30 days following the conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDLbrDM1S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2148510915.USD","06990","LU1979443071.USD","BK0060","LU1934453819.USD","BK0239","LU1064130708.USD","002422","LU1064131003.USD","LU0196878994.USD"],"gpt_icon":0},{"id":"2601828938","title":"Kelun-Biotech to Attend the 44TH J.p. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies","url":"https://stock-news.laohu8.com/highlight/detail?id=2601828938","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601828938?lang=en_us&edition=fundamental","pubTime":"2026-01-07 10:44","pubTimestamp":1767753890,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA5J2JZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","LU2237443978.SGD","LU1914381329.SGD","LU0211327993.USD","LU2462157665.USD","LU0211326839.USD","LU1548497426.USD","LU0943347566.SGD","BK4533","LU2213496289.HKD","LU0208291251.USD","LU1720051017.SGD","LU1974910355.USD","LU0640476718.USD","LU0234572021.USD","LU1670628061.USD","IE00BYXW3230.USD","LU1064131342.USD","IE00B1BXHZ80.USD","LU2242649171.HKD","LU0942090050.USD","LU0256863811.USD","IE00BLSP4239.USD","LU2023250843.SGD","LU2023250330.USD","LU0106261372.USD","IE00BBT3K403.USD","06990","LU0345770308.USD","LU1917777945.USD","LU2456880835.USD","LU2746668461.USD","LU1496350502.SGD","LU1244550494.USD","LU2756315664.SGD","LU2054465674.USD","BK4516","BK4534","LU0820562030.AUD","LU0267386448.USD","IE00BJLML261.HKD","LU1267930490.SGD","IE00BZ1G4Q59.USD","BK4581","LU1668664300.SGD","LU2746668974.SGD","LU2756315318.SGD","LU0265550359.USD","LU0203347892.USD","LU0868494708.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":115,"code":"91000000","status":"200"}]}}